MedPath

Soma

These highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) tablets for oral use, CIVInitial U.S. Approval: 1959

Approved
Approval ID

6297cf20-830a-11dc-94c8-0002a5d5c51b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 15, 2023

Manufacturers
FDA

Meda Pharmaceuticals Inc.

DUNS: 051229602

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carisoprodol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0037-2250
Application NumberNDA011792
Product Classification
M
Marketing Category
C73594
G
Generic Name
Carisoprodol
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (1)

CARISOPRODOLActive
Quantity: 250 mg in 1 1
Code: 21925K482H
Classification: ACTIB

Carisoprodol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0037-2001
Application NumberNDA011792
Product Classification
M
Marketing Category
C73594
G
Generic Name
Carisoprodol
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification

INGREDIENTS (1)

CARISOPRODOLActive
Quantity: 350 mg in 1 1
Code: 21925K482H
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.